Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$6.83 - $8.48 $1,707 - $2,120
250 New
250 $2,000
Q3 2023

Oct 31, 2023

SELL
$11.94 - $14.6 $2,985 - $3,650
-250 Reduced 33.33%
500 $6,000
Q2 2023

Jul 28, 2023

BUY
$13.55 - $16.92 $10,162 - $12,690
750 New
750 $10,000
Q4 2021

Feb 09, 2022

BUY
$12.54 - $14.77 $9,405 - $11,077
750 New
750 $10,000
Q3 2020

Nov 06, 2020

SELL
$14.95 - $18.91 $88,952 - $112,514
-5,950 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$16.74 - $20.68 $2,343 - $2,895
140 Added 2.41%
5,950 $121,000
Q3 2019

Nov 01, 2019

BUY
$15.64 - $19.18 $7,820 - $9,590
500 Added 9.42%
5,810 $103,000
Q3 2018

Nov 05, 2018

BUY
$20.39 - $28.03 $12,234 - $16,818
600 Added 12.74%
5,310 $118,000
Q1 2018

May 09, 2018

BUY
$27.75 - $33.71 $130,702 - $158,774
4,710 New
4,710 $133,000

Others Institutions Holding BAYRY

About BAYER AG SPONS ADR


  • Ticker BAYRY
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,929,700,096
  • Market Cap $22.6B
More about BAYRY
Track This Portfolio

Track Alpha Mark Advisors, LLC Portfolio

Follow Alpha Mark Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.